Liabilities / Assets
83rd percentile
Higher debt load relative to assets than 83% of similar nonprofits.
The Bioexec Institute Inc
990EZ • Fiscal year 2024 • EIN 20-4034018
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.19x
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
Score unavailable
Net margin requires both revenue and expenses on this filing.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
7th percentile
Faster asset growth than 7% of similar nonprofits.
Revenue Growth
1st percentile
Faster revenue growth than 1% of similar nonprofits.
Balance Sheet
Assets
Down$14,046
Down $28,337 (-67%) from 2023
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Down$2,600
Down $2,392 (-48%) from 2023
Revenue And Expenses
Revenue
$0
No earlier filing loaded for comparison.
Expenses
Down$25,945
Down $8,758 (-25%) from 2023
Net Income
-$25,945
No earlier filing loaded for comparison.
Historical Trend
Filing Detail Status
This 2024 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2023 to Jun 30, 2024
Mission and Program Overview
Mission
To encourage the building and strengthening of collaborative working relationships amongst life science industry leaders in a global context; promote continued investment and growth in the life sciences; to review exciting new opportunities for future investment and innovation.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2024 • Form 990EZSummary only. Only limited summary data is available for this year.
- Assets
- $14,046
- Liabilities
- $2,600
- Net assets
- -
- Revenue
- $0
- Expenses
- $25,945
- Net income
- -$25,945